Steve Mertens is Chief Technology Officer of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 163,141 shares of NMTC, which is worth approximately $140,301. The most recent transaction as insider was on May 31, 2023, when has been sold 252 shares (Common Stock) at a price of $1.21 per share, resulting in proceeds of $304. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K
4.97% 3M change
11.29% 12M change
Total Value Held $140,301

Steve Mertens Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2023
SELL
Payment of exercise price or tax liability
$304 $1.21 p/Share
252 Reduced 0.3%
84,940 Common Stock
Apr 30 2023
SELL
Payment of exercise price or tax liability
$388 $1.54 p/Share
252 Reduced 0.29%
85,192 Common Stock
Apr 21 2023
BUY
Grant, award, or other acquisition
-
50,000 Added 36.92%
85,444 Common Stock
Mar 31 2023
SELL
Payment of exercise price or tax liability
$405 $1.61 p/Share
252 Reduced 0.71%
35,444 Common Stock
Feb 03 2023
SELL
Payment of exercise price or tax liability
$8,899 $1.47 p/Share
6,054 Reduced 14.5%
35,696 Common Stock
Feb 03 2022
BUY
Grant, award, or other acquisition
-
41,750 Added 50.0%
41,750 Common Stock
SM

Steve Mertens

Chief Technology Officer
Eden Prairie, MN

Track Institutional and Insider Activities on NMTC

Follow NEUROONE MEDICAL TECHNOLOGIES Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Track Activities on NMTC